X4 Pharmaceuticals (XFOR) Treasury Shares (2019 - 2025)

X4 Pharmaceuticals has reported Treasury Shares for 7 years, with the latest figure at $73381.0 in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares fell 63.12% year-over-year to $73381.0; the trailing twelve-month figure through Dec 2025 stood at $73381.0 (down 63.12% YoY), and the FY2025 full-year result was $73381.0, down 63.12% from the prior year.
• Treasury Shares for Q4 2025 stood at $73381.0, down from $99232.0 in the prior quarter.
• The five-year high for Treasury Shares was $8.4 million in Q1 2024, with the low at $73381.0 in Q4 2025.
• Historically, Treasury Shares has averaged $2.8 million across 5 years, with a median of $1.5 million in 2022.
• Annual changes were most pronounced in 2023 — Treasury Shares soared 298.83% — and 2025, when it plunged 98.78%.
• X4 Pharmaceuticals' Treasury Shares stood at $925101.0 in 2021, then jumped by 81.66% to $1.7 million in 2022, then soared by 85.58% to $3.1 million in 2023, then sank by 93.62% to $198995.0 in 2024, then sank by 63.12% to $73381.0 in 2025.
• The last three Treasury Shares figures came in at $73381.0 (Q4 2025), $99232.0 (Q3 2025), and $333264.0 (Q2 2025), per Business Quant data.